[Translation] A phase III, randomized, observer-blind, positive-controlled, parallel-group, multicenter clinical study on the safety and efficacy of 0.24% cetirizine hydrochloride eye drops in Chinese patients with allergic conjunctivitis
评价0.24%盐酸西替利嗪滴眼液在过敏性结膜炎患者中的安全性和有效性
[Translation] To evaluate the safety and efficacy of 0.24% cetirizine hydrochloride eye drops in patients with allergic conjunctivitis